Project/Area Number |
10670499
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Gastroenterology
|
Research Institution | Saitama Medical School |
Principal Investigator |
OTA Shinichi SAITAMA MEDICAL SCHOOL, MEDICAL DEPARTMENT, PROFESSOR, 医学部, 教授 (30185269)
|
Co-Investigator(Kenkyū-buntansha) |
BAMBA Hiromi SAITAMA MEDICAL SCHOOL, MEDICAL DEPARTMENT, RESEARCH ASSISTANT, 医学部, 実験助手
KATO Akira SAITAMA MEDICAL SCHOOL, MEDICAL DEPARTMENT, ASSISTANT, 医学部, 助手 (30204457)
伴場 裕巳 埼玉医科大学, 医学部, 研究助手
|
Project Period (FY) |
1998 – 1999
|
Project Status |
Completed (Fiscal Year 1999)
|
Budget Amount *help |
¥3,100,000 (Direct Cost: ¥3,100,000)
Fiscal Year 1999: ¥1,400,000 (Direct Cost: ¥1,400,000)
Fiscal Year 1998: ¥1,700,000 (Direct Cost: ¥1,700,000)
|
Keywords | NSAIDs / PROSTAGLANDIN / COX-2 / COLON CARCINOGENESIS / COLON ADENOMA / VEGF / PROSTAGLANDIN RECEPTORS / MACROPHAGE / PPArγ / NSAID / COX |
Research Abstract |
We investigated the localization of cyclooxygenase (COX)-2, a possible target of nonsteroidal anti-inflammatory drugs (NSAIDs) in the prevention of colon carcinogenesis. Then effects of prostaglandins on vascular endothelial growth factor (VEGF), an essential factor in tumor angiogenesis, production was studied. Results are as follows; a. High expression of COX-2 was detected in sub-epithelial interstitial cells, possibly macrophages, broadly present in the surface area of human adenomas. b. Coz-2 was only partly and weekly expressed in human advanced colon cancer. c. Prostaglandin (PG) E dramatically increased the production of VEGF by human macrophages but not by human colonic adenoma cells or cancer cells. d. This action was mediated by the increase of cAMP through EPィイD22ィエD2 and EPィイD24ィエD2 PGE receptors e. PGJ2, an agonist of nuclear receptor PPAR γ, also dramatically increased VEGF production by human macrophages. These results suggest that PGs produced by macrophaged of human colonic adenomas may play important roles in human colon carcinogenesis through the induction of VEGF. NSAIDs possibly prevent human coloncarcinogenesis by the suppression of this step.
|